pdufa.bio

PAPZIMEOS (zopapogene imadenovec-drba)

Updated ยทnext FDA decision on the calendar

PAPZIMEOS (zopapogene imadenovec-drba) 1 FDA decision on record below. Every date links its source.

PGEN catalyst hub

About this program

We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

PDUFA · May 27, 2026 ✓ ApprovedPGEN

Questions

When is PAPZIMEOS (zopapogene imadenovec-drba)'s next FDA decision or readout?

No upcoming catalyst is on our calendar for PAPZIMEOS (zopapogene imadenovec-drba); 1 FDA decision is on record below.

What happened at PAPZIMEOS (zopapogene imadenovec-drba)'s most recent FDA decision?

On May 27, 2026 the FDA approved the application. The decision page carries the source document and the measured share-price reaction.